No Detail Found!

Multisystem Inflammatory Disease in a Child with Multiple Heterozygous Variants: A Case Suggesting Oligogenic Interaction

Author(s)
Sharif Alhajlah Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia
Abstract
The interpretation of multiple heterozygous Variants of Uncertain Significance (VUS) poses a significant challenge in clinical genomics, particularly in consanguineous pedigrees. Case Presentation: An example of a child with a severe multisystem disorder is that of a 10 year-old boy born out of a consanguinity relationship with manifested symptoms of chronic inflammatory bone pain (diagnosed with chronic non-bacterial osteomyelitis through biopsy), severe growth failure and chronic gastrointestinal symptoms. Whole-exome sequencing showed a heterozygous likely pathogenic variant in PAH (c.898G>T; p.Ala300Ser), a heterozygous likely pathogenic variant in PRKRA (c.796G>A; p.Ala266Thr), a heterozygous VUS in ALDH18A1 (c.1619A>G; p.Glu540Gly) and a compound heterozygote VUS in the SI gene. Conclusion: Variant prioritization was guided by ACMG/AMP classification, phenotypic concordance and pathway-level biological plausibility, with additional support from segregation analysis and functional correlation, including biochemical confirmation of sucrase-isomaltase deficiency. We suggest a hypothesis of a synergistic heterozygotic effect of PRKRA variants on inflammatory signaling, along with metabolic stress factors of the PAH and ALDH18A1 variants and nutritional deficiency of partial Sucrase-Isomaltase deficiency (SI) reduced the initiation threshold to severe CRMO.
Publication Details
Page(s) 196-199
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: s1, Year: 2026

Request the full text from PASTIC

Keywords
Chronic Non-Bacterial Osteomyelitis (CRMO), Variant of Uncertain Significance (VUS), Synergistic Heterozygosity
References
Gagnier J.J. .2013 .. The CARE Guidelines: Consensus-Based Clinical Case Reporting Guideline Development.” Journal of Clinical Epidemiology, 08(2013) : 46-51.
Vockley J. .2019 .Complex Patterns of Inheritance, Including Synergistic Heterozygosity, in Inborn Errors of Metabolism: Implications for Precision Medicine Driven Diagnosis. Molecular Genetics and Metabolism, 08(1-2) : 10-16.
Schäffer A.A. .2013 .Digenic Inheritance in Medical Genetics. ” Journal of Medical Genetics, 50(10) : 641-652.
Vockley J. .2000 .Synergistic Heterozygosity: Disease Resulting from Multiple Partial Defects in One or More Metabolic Pathways. Molecular Genetics and Metabolism, 3066(1-2) : 10-18.
Cammarata-Mouchabeck A. .2021 .PRKRA (DYT16) Mutations in the Genetic Landscape of Dystonia. Parkinsonism & Related Disorders, 01 : 108-112.
Chukwurah E. . .A Tale of Two Proteins: PACT and PKR and Their Roles in Inflammation. The FEBS Journal, 288(2021) : 1750-1763.
Farabaugh K.T. .2020 .PACT-Mediated PKR Activation Acts as a Hyperosmotic Stress Sensor That Is Counter-Regulated by GADD34. , 9 : .
Donnelly N.,RNase L Signaling N. .2013 .Pathways in Inflammatory Diseases. Cytokine & Growth Factor Reviews, 04(2013) : 451-460.
Danialifar T.F. . .Genetic and Acquired SucraseIsomaltase Deficiency: A Clinical Review. ” Journal of Pediatric Gastroenterology and Nutrition, 78(2024) : 12151-21.
Haberman Y.,Congenital Sucrase-Isomaltase Deficiency A Novel,Compound Heterozygous Mutation Causing Aberrant Protein Localization A Novel . .. ” Journal of Pediatric Gastroenterology and Nutrition, 64(2017) : 768-772.
Marco-Marín C.,-Carboxylate Synthetase Deficiency: An Emergent Multifaceted Urea Cycle-Related Disorder C. . .. ” Journal of Inherited Metabolic Disease, 43(2020) : 477-487.
Colonna M.,Metabolism Antioxidant . .Functional Assessment of Homozygous ALDH18A1 Variants Reveals Alterations in Amino Acid. Human Molecular Genetics, 32(2023) : 732-744.
Bicknell L.S. .2008 .A Missense Mutation in ALDH18A1, Encoding Δ1-Pyrroline-5-Carboxylate Synthase (P5CS), Causes an Autosomal Recessive Neurocutaneous Syndrome. European Journal of Human Genetics, 91(10) : 1176-1186.
Scholl-Bürgi S. .2015 .Phenylketonuria: A New Look at an Old Topic. ” Journal of Pediatric Endocrinology and Metabolism, 28(9-10) : 0128-979.
Giri M.,Vockley J. .2021 .. Oligogenic and Digenic Diseases: Case Studies.” Molecular Genetics and Metabolism, 03(2021) : 1-11.
0

Citations

0

Downloads

15

Views